Amplitude Surgical (AMPLI) H2 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
H2 23/24 earnings summary
13 Jun, 2025Executive summary
Consolidated annual sales reached €106.0 million, up 6.3% at constant exchange rates year-over-year.
Fourth quarter sales grew 7.0% at constant exchange rates compared to the same quarter last year.
Growth was driven by both domestic and international markets, with France up 5.0% and international sales up 9.9% at constant exchange rates.
Financial highlights
Full-year sales increased 5.8% at current exchange rates and 6.3% at constant exchange rates year-over-year.
Q4 sales totaled €26.4 million, up 6.6% at current exchange rates and 7.0% at constant exchange rates.
Direct sales, representing 93% of total sales, rose 6.3% at constant exchange rates.
Outlook and guidance
Annual results for 2023-24 will be released on October 23, 2024, after market close.
Latest events from Amplitude Surgical
- Revenue up 5.7% year-over-year; EBITDA margin expected at 27% for 2024-25.AMPLI
H2 2025 TU24 Jul 2025 - Q1 sales up 7.5% at constant exchange rates, driven by international and French growth.AMPLI
Q1 24/2513 Jun 2025 - Sales up 6.4% at constant exchange rates, driven by robust international and French growth.AMPLI
Q3 24/256 Jun 2025 - Sales up 6.3% in H1 2024-25, driven by international and French market growth.AMPLI
H1 24/256 Jun 2025